BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21072224)

  • 1. Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial.
    Harding-Esch EM; Edwards T; Mkocha H; Munoz B; Holland MJ; Burr SE; Sillah A; Gaydos CA; Stare D; Mabey DC; Bailey RL; West SK;
    PLoS Negl Trop Dis; 2010 Nov; 4(11):e861. PubMed ID: 21072224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlamydial positivity of nasal discharge at baseline is associated with ocular chlamydial positivity 2 months following azithromycin treatment.
    Gower EW; Solomon AW; Burton MJ; Aguirre A; Muñoz B; Bailey R; Holland M; Makalo P; Massae P; Mkocha H; Mabey DC; West SK
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4767-71. PubMed ID: 17065486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between ocular bacterial carriage and follicular trachoma following mass azithromycin distribution in The Gambia.
    Burr SE; Hart JD; Edwards T; Baldeh I; Bojang E; Harding-Esch EM; Holland MJ; Lietman TM; West SK; Mabey DC; Sillah A; Bailey RL
    PLoS Negl Trop Dis; 2013; 7(7):e2347. PubMed ID: 23936573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?
    Harding-Esch EM; Edwards T; Sillah A; Sarr I; Roberts CH; Snell P; Aryee E; Molina S; Holland MJ; Mabey DC; Bailey RL
    PLoS Negl Trop Dis; 2009 Dec; 3(12):e573. PubMed ID: 20027217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children.
    Lee JS; Muñoz BE; Mkocha H; Gaydos CA; Quinn TC; West SK
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2761. PubMed ID: 24722392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial.
    Amza A; Kadri B; Nassirou B; Stoller NE; Yu SN; Zhou Z; Chin S; West SK; Bailey RL; Mabey DC; Keenan JD; Porco TC; Lietman TM; Gaynor BD;
    PLoS Negl Trop Dis; 2012; 6(4):e1586. PubMed ID: 22545165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of a prototype point-of-care test for ocular Chlamydia trachomatis under field conditions in The Gambia and Senegal.
    Harding-Esch EM; Holland MJ; Schémann JF; Molina S; Sarr I; Andreasen AA; Roberts Ch; Sillah A; Sarr B; Harding EF; Edwards T; Bailey RL; Mabey DC
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1234. PubMed ID: 21829735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naïve trachoma-hyperendemic communities of the Bijagós Archipelago, Guinea Bissau.
    Last AR; Burr SE; Weiss HA; Harding-Esch EM; Cassama E; Nabicassa M; Mabey DC; Holland MJ; Bailey RL
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2900. PubMed ID: 24967629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
    Harding-Esch EM; Holland MJ; Schémann JF; Sillah A; Sarr B; Christerson L; Pickering H; Molina-Gonzalez S; Sarr I; Andreasen AA; Jeffries D; Grundy C; Mabey DCW; Herrmann B; Bailey RL
    Parasit Vectors; 2019 Oct; 12(1):497. PubMed ID: 31640755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for control of trachoma: observational study with quantitative PCR.
    Solomon AW; Holland MJ; Burton MJ; West SK; Alexander ND; Aguirre A; Massae PA; Mkocha H; Muñoz B; Johnson GJ; Peeling RW; Bailey RL; Foster A; Mabey DC
    Lancet; 2003 Jul; 362(9379):198-204. PubMed ID: 12885481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.
    Burton MJ; Holland MJ; Makalo P; Aryee EA; Sillah A; Cohuet S; Natividad A; Alexander ND; Mabey DC; Bailey RL
    PLoS Negl Trop Dis; 2010 Oct; 4(10):. PubMed ID: 20957147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field evaluation of the Cepheid GeneXpert Chlamydia trachomatis assay for detection of infection in a trachoma endemic community in Tanzania.
    Jenson A; Dize L; Mkocha H; Munoz B; Lee J; Gaydos C; Quinn T; West SK
    PLoS Negl Trop Dis; 2013; 7(7):e2265. PubMed ID: 23861986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for contamination with C. trachomatis in the household environment of children with active Trachoma: A cross-sectional study in Kongwa, Tanzania.
    West SK; Nanji AA; Mkocha H; Munoz B; Gaydos C; Quinn TC
    PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007834. PubMed ID: 31869324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for active trachoma in The Gambia.
    Harding-Esch EM; Edwards T; Sillah A; Sarr-Sissoho I; Aryee EA; Snell P; Holland MJ; Mabey DC; Bailey RL
    Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1255-62. PubMed ID: 18502459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results.
    Yohannan J; Munoz B; Mkocha H; Gaydos CA; Bailey R; Lietman TA; Quinn T; West SK
    JAMA Ophthalmol; 2013 Apr; 131(4):431-6. PubMed ID: 23392481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
    Harding-Esch EM; Sillah A; Edwards T; Burr SE; Hart JD; Joof H; Laye M; Makalo P; Manjang A; Molina S; Sarr-Sissoho I; Quinn TC; Lietman T; Holland MJ; Mabey D; West SK; Bailey R;
    PLoS Negl Trop Dis; 2013; 7(6):e2115. PubMed ID: 23785525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonocular Chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area.
    West S; Muñoz B; Bobo L; Quinn TC; Mkocha H; Lynch M; Mmbaga BB; Viscidi R
    Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3194-8. PubMed ID: 8407229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular trachoma and trichiasis prevalence in an urban community in The Gambia, West Africa: is there a need to include urban areas in national trachoma surveillance?
    Quicke E; Sillah A; Harding-Esch EM; Last A; Joof H; Makalo P; Bailey RL; Burr SE
    Trop Med Int Health; 2013 Nov; 18(11):1344-52. PubMed ID: 24033501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.
    Stare D; Harding-Esch E; Munoz B; Bailey R; Mabey D; Holland M; Gaydos C; West S
    Ophthalmic Epidemiol; 2011 Feb; 18(1):20-9. PubMed ID: 21275593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program.
    Pant BP; Bhatta RC; Chaudhary JS; Awasthi S; Mishra S; Sharma S; Cuddapah PA; Gwyn SE; Stoller NE; Martin DL; Keenan JD; Lietman TM; Gaynor BD
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004462. PubMed ID: 26871898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.